Hansoh Pharmaceutical Group Company Limited reported that authorized share capital remained at HKD200,000, with no changes in the total of 20,000,000,000 authorized shares at a par value of HKD0.00001. The total issued ordinary shares stayed at 6,055,150,070, unchanged from the previous month. Public float requirements continued to be met at 16.21%.
The company noted zero coupon convertible bonds due 2033 amounting to HKD4.68 billion, convertible at a price of HKD57.39 into approximately 81.55 million new shares. No other share options, warrants, or additional arrangements to issue shares were reported during the period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments